Compare CSTL & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTL | BH |
|---|---|---|
| Founded | 2007 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2019 | N/A |
| Metric | CSTL | BH |
|---|---|---|
| Price | $40.31 | $460.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $46.00 | N/A |
| AVG Volume (30 Days) | ★ 331.6K | 63.7K |
| Earning Date | 02-26-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.91 |
| Revenue | $343,530,000.00 | ★ $386,507,000.00 |
| Revenue This Year | $2.54 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $690.28 |
| Revenue Growth | ★ 10.15 | 6.87 |
| 52 Week Low | $14.59 | $195.05 |
| 52 Week High | $42.18 | $463.13 |
| Indicator | CSTL | BH |
|---|---|---|
| Relative Strength Index (RSI) | 57.91 | 84.24 |
| Support Level | $38.73 | $346.56 |
| Resistance Level | $41.60 | $364.95 |
| Average True Range (ATR) | 1.58 | 18.15 |
| MACD | -0.12 | 9.64 |
| Stochastic Oscillator | 62.75 | 98.31 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.